STANLIB Equity A | LIWA

Performance History30/04/2017
Growth of 1,000 (ZAR)
STANLIB Equity A
          | 
          LIWA
Fund25.18.78.2-5.82.8
+/-Cat5.0-1.96.5-10.0-2.5
+/-Idx3.6-2.23.0-8.4-4.8
 
Key Stats
NAV
29/05/2017
 ZAR 257.19
Day Change 0.57%
Morningstar Category™ South Africa & Namibia Equity
ISIN ZAE000025078
Fund Size (Mil)
26/05/2017
 ZAR 3502.63
Share Class Size (Mil)
26/05/2017
 ZAR 517.96
Max Initial Charge 5.70%
Ongoing Charge
-
  -%
Investment Objective: STANLIB Equity A | LIWA
The Fund’s objective is the steady growth of income and capital, a reasonable level of current income and the maximum stability for capital invested. The securities to be included will consist of securities, non-equity securities and participatory interests of collective investment schemes in securities. This portfolio may have a maximum of 15% direct and/or indirect foreign exposure.
Returns
Trailing Returns29/05/2017
YTD3.05
3 Years Annualised3.08
5 Years Annualised11.33
10 Years Annualised6.69
12 Month Yield 0.37
Dividend Paying Frequency Half-yearly
Management
Manager Name
Start Date
Paul Swanson
01/08/2009
Inception Date
03/07/2000
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
FTSE/JSE All Share SWIX TR ZARFTSE/JSE All Share TR ZAR
Portfolio Profile for  STANLIB Equity A | LIWA30/04/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks97.470.0097.47
Bonds0.000.000.00
Cash2.620.272.35
Other0.180.000.18
Top 5 Regions%
Africa56.60
United States18.41
United Kingdom15.72
Asia - Emerging3.05
Eurozone2.47
Top 5 Sectors%
Financial Services24.73
Consumer Defensive14.63
Technology13.78
Consumer Cyclical13.04
Healthcare10.10
Top 5 HoldingsSector%
SFL STANLIB High Alpha Global Eq... 28.84
Naspers LtdTechnologyTechnology8.51
British American Tobacco PLCConsumer DefensiveConsumer Defensive5.29
Firstrand LimitedFinancial ServicesFinancial Services4.29
Aspen Pharmacare Holdings PLCHealthcareHealthcare3.84
STANLIB Equity A | LIWA